MNOV vs TXT · rev $645.4K vs P/E 19, rev $7.52B
MediciNova Inc (MNOV) versus Textron Inc (TXT) — a side-by-side from cached financials, not a winner call.
MediciNova Inc (MNOV) is a biotechnology company listed on NASDAQ.
Textron Inc (TXT) is a aerospace & defense company listed on US.
Latest reported MNOV revenue for 2026-06-30 was $645.4K. Net income was -$4.9M. MNOV currently screens at market cap $66.0M.
Latest reported TXT revenue for 2026-07-04 was $7.52B. Net income was $468.0M. TXT currently screens at market cap $14.85B and trailing P/E 18.5.
MNOV currently screens at market cap $66.0M. TXT currently screens at market cap $14.85B and trailing P/E 18.5.
Not investment advice. Open the MNOV and TXT stock pages for the full models.
Not investment advice.